A Safety and Efficacy Study of Eltrombopag in Subjects With AML
Clinical trial NCT01890746 · COMPLETED
Trial details
- NCT number
- NCT01890746
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-05
- Primary completion
- 2015-03-13
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.